ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,315
-1,22%
Bitcoin
64 423,37
-0,66%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
13/02/201914h54Dow Jones NewsKing of Generics Pushes Into Biotech DrugsNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201913h00Business WireTeva Reports Fourth Quarter and Full Year 2018 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201917h13Business WireTeva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin)NYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201900h57Business WireTeva Announces Launch of ALYQ™ (Tadalafil Tablets USP), a Generic Version of ADCIRCA® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201920h33Dow Jones NewsAmgen, Eli Lilly Migraine Drugs to Be Covered by UnitedHealth Unit -ReutersNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201912h50Business WireTeva Receives Positive Committee for Medicinal Products for Human Use (CHMP) Opinion for AJOVY® (fremanezumab) for the Proph...NYSE:TEVATeva Pharmaceutical Industries Ltd
16/01/201919h50Dow Jones NewsFDA Approves Teva's Generic Version of Epilepsy DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
14/01/201922h00Business WireTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results at 8 a.m. ET on February 13, 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/201918h45Business WireTeva to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
03/01/201902h28Business WireTeva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl ProductNYSE:TEVATeva Pharmaceutical Industries Ltd
27/12/201818h05Business WireTeva Announces US Launch of a Generic Version of Elidel® (Pimecrolimus) Cream, 1%NYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201817h06Business WireADDING MULTIMEDIA Teva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/12/201822h39Dow Jones NewsFDA Approves Teva's Digital Asthma Inhaler With Built-In SensorsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/12/201821h19Business WireTeva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfat...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/12/201822h09Dow Jones NewsFTC Approves Teva Petition to Give Pfizer More Time to Sell DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
17/12/201814h00Business WireTeva Announces Positive Topline Phase IIIb Results with Fremanezumab in Adults with Migraine Who Did Not Respond to Multiple ...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/12/201800h31Business WireCelltrion & Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER...NYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201823h57Dow Jones NewsFDA Approves Herceptin Biosimilar HerzumaNYSE:TEVATeva Pharmaceutical Industries Ltd
12/12/201816h33Dow Jones NewsFDA Issues Warning Letter to Zhejiang Huahai in Valsartan RecallNYSE:TEVATeva Pharmaceutical Industries Ltd
28/11/201821h38Business WireCelltrion & Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Ly...NYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201818h08Dow Jones NewsTeva Releases Generic EpiPen in Limited Doses in the U.S. -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201817h02Dow Jones NewsTeva Releases Limited Doses of Generic Version of EpiPen in U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201816h06Business WireTeva’s Generic Version of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in ...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201815h19Dow Jones NewsTeva Shares Rise as Investors Greet Progress in TurnaroundNYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201813h16Dow Jones NewsTeva 3Q Sales Fell 19%NYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201812h00Business WireTeva Reports Third Quarter 2018 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201814h23Business WireTeva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in IsraelNYSE:TEVATeva Pharmaceutical Industries Ltd
12/10/201819h30Dow Jones NewsMylan Gets Favorable Appeals Court Ruling in Patent Dispute Over Teva's CopaxoneNYSE:TEVATeva Pharmaceutical Industries Ltd
11/10/201811h00Business WireTeva nutzt Patientenerfahrungen zur Unterstützung von Patienten mit chronischen ErkrankungenNYSE:TEVATeva Pharmaceutical Industries Ltd
11/10/201811h00Business WireTeva Draws on Patient Experience to Empower Those Living with Chronic ConditionsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

BOV
FCXO34M
Freeport McMoRan
BOV
SEED13
Seedel Tecnologia Ltda
NASDAQ
CGEN
Compugen
LSE
IVPB
Invesco Select
LSE
ANRJ
Amundiglblhdrgn
NYSE
DDR
Developers Realty
NYSE
DAL
Delta Air Lines
NASDAQ
LMNX
Luminex
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés